Giuseppe Nocentini
Università degli Studi di Perugia
H-index: 42
Europe-Italy
Top articles of Giuseppe Nocentini
Correction: Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice
Neuropsychopharmacology
2024/5
Salvatore Cuzzocrea
H-Index: 59
Giuseppe Nocentini
H-Index: 21
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper
Allergy
2024/1/24
Heather J Bax
H-Index: 18
Giuseppe Nocentini
H-Index: 21
Matthias Preusser
H-Index: 55
Reka Toth
H-Index: 13
Sophia N Karagiannis
H-Index: 31
A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease
bioRxiv
2024
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for …
Allergy
2023/12/18
Impact of endocrine disruptors on peripheral blood mononuclear cells in vitro: Role of gender
Archives of Toxicology
2023/12
Giuseppe Nocentini
H-Index: 21
Emanuela Corsini
H-Index: 29
Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World
Vaccines
2023/4/21
Giuseppe Nocentini
H-Index: 21
Overexpression of Potential Markers of Regulatory and Exhausted CD8+ T Cells in the Peripheral Blood Mononuclear Cells of Patients with B-Acute Lymphoblastic …
International Journal of Molecular Sciences
2023/2/24
Simona Ronchetti
H-Index: 24
Giuseppe Nocentini
H-Index: 21
Association of GILZ with MUC2, TLR2, and TLR4 in Inflammatory Bowel Disease
International Journal of Molecular Sciences
2023/1/23
Giuseppe Nocentini
H-Index: 21
Simona Ronchetti
H-Index: 24
Human glucocorticoid-induced leucine zipper is involved in mucosal barrier dysfunction in IBD
BRITISH JOURNAL OF PHARMACOLOGY
2023
Giuseppe Nocentini
H-Index: 21
Simona Ronchetti
H-Index: 24
Ormoni Surrenalici
2022/10/4
Giuseppe Nocentini
H-Index: 21
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines
2022/9/29
Giuseppe Nocentini
H-Index: 21
Pricing for multi-indication medicines: A discussion with Italian experts
Pharmadvances
2022/7
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer …
Urologic Oncology: Seminars and Original Investigations
2022/3/1
Vincenza Maulà
H-Index: 4
Giuseppe Nocentini
H-Index: 21
Validation in an independent cohort of MiR-122, MiR-1271, and MiR-15b as urinary biomarkers for the potential early diagnosis of clear cell renal cell carcinoma
Cancers
2022/2/22
Vincenza Maulà
H-Index: 4
Giuseppe Nocentini
H-Index: 21
Gli straordinari progressi dei trattamenti anti-retrovirali e il nuovo profilo del paziente con HIV
QUADERNI DELLA SIF
2022
Diabetic retinopathy: new pharmacological targets
Pharm. Adv
2022
Investigation of the effects of endocrine disruptors on T cells differentiation
Toxicology Letters
2022
PHARMACOLOGICAL APPROACHES TO SARS-CoV-2 INFECTION: FROM DRUG REPOSITIONING FOR COVID-19 TREATMENT TO DISEASE ARREST/PREVENTION WITH MoAbs AND NOVEL ANTIVIRALS
Pharmadvances
2022
IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer
Oncoimmunology
2021/1/1
Immune modulation via T regulatory cell enhancement: disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—an EAACI …
2021/1
Onur Boyman
H-Index: 39
Kian Fan Chung
H-Index: 81
Antonios Kolios
H-Index: 17
Giuseppe Nocentini
H-Index: 21
Cristiana Stellato
H-Index: 27
Co-Authors
